Board of Directors

Rob has spent the past 20 years with the global consulting firm KPMG, where he rose to the top and served as Chairman of KPMG Victoria, National Managing Partner for KPMG Australia’s Enterprise Division and National Managing Partner for KPMG’s M&A Division. Whilst in these roles, Rob was a member of KPMG’s National Executive Committee (NEC), which oversees and is responsible for the Firm’s turnover, strategic decision making, profitability and operations. Rob has a demonstrated track record of leading and growing large scale and complex businesses. He has played a significant role in advising clients (public, private, and global subsidiaries) on commercial matters, public transitions, corporate governance, M&A and has engaged with Government and Regulators. With extensive experience in corporate advisory, Rob has deep commercial and industry knowledge across financial services, asset and wealth management, property, insurances and consumer & industrial markets.

Teri Thomas is the CEO and Managing Director of Mach7 Technologies, bringing global experience in healthcare technology, operational leadership, and strategic growth. Before joining Mach7, Teri was CEO of Volpara Health Technologies (ASX:VHT), where she led a successful turnaround and positioned the company for its acquisition by Lunit, where she also served as Chief Business Officer. She previously spent 20 years in a variety of roles at Epic, the leading US electronic medical record company, and held executive roles at Orion Health, overseeing global sales and corporate development.

A registered nurse with a Master of Science degree, Teri pairs clinical insight with a proven track record in scaling businesses, delivering operational efficiencies, and fostering strong, mission-driven cultures. She is committed to leading Mach7 through its next phase of growth and innovation in medical imaging and data management.

Dr. Eliot Siegel is a well-known thought leader in the world of radiology and imaging informatics and artificial intelligence applications in medicine. He is currently Professor at the University of Maryland School of Medicine, Department of Diagnostic Radiology, and also works for the Veterans Affairs Maryland Healthcare System, both in Baltimore, MD as well as adjunct professor of computer science and biomedical engineering at the undergraduate campuses of the University of Maryland. He is a pioneer and co-founder of United Theranostics, a company created to bring state-of-the-art radiopharmaceuticals to patients for cancer therapy. Under his guidance, the VA Maryland Healthcare System became the first filmless healthcare enterprise in the World. He has written over 300 articles and book chapters about PACS (Picture Archiving and Communication Systems) and digital imaging, and has edited numerous books on the topic, including Filmless Radiology and Security Issues in the Digital Medical Enterprise. He has given more than 1,000 presentations throughout the world on a broad range of topics involving the use of computers in medicine and artificial intelligence. Dr. Siegel was symposium chairman for the Society of Photo-optical and Industrial Engineers (SPIE) Medical Imaging Meeting for three years and has been honored as a fellow in that organization as well as the American College of Radiology and the Society of Imaging Informatics in Medicine. He is also a Board member of Carestream Health and serves on numerous advisory boards in medical imaging.

Rebecca Thompson was appointed to the Board of Mach7 Technologies in November 2023 following an advisory role with the Company in the preceding year and currently serves as Chair of the Audit and Risk Committee. With more than 25 years’ experience in senior roles with global investment banks, ASX-listed companies and a fintech start-up, Rebecca brings deep expertise in financial markets, business development and strategic communications. Her broad industry exposure spans real estate, building materials, healthcare, resources and software.

Before joining Mach7, Rebecca held senior executive roles including Head of Investor Relations at CSR Limited (ASX:CSR), where she enhanced market transparency and investor engagement ahead of the company’s successful acquisition by Saint-Gobain in 2024. She has also served as a Director at KPMG Advisory and Executive Director at J.P. Morgan, where she advised ASX-listed clients on equity market positioning and global investor strategy. Earlier in her career, she held senior roles in corporate affairs, equity research, and financial journalism, building a strong foundation in market analysis and stakeholder engagement.

Rebecca is also a Non-Executive Director of Independent Community Living Australia (ICLA) and co-founder of MarketMeter, an online market-insights platform serving ASX-listed companies and institutional investors. She holds a Bachelor of Economics from the University of Sydney, a Graduate Diploma in Applied Finance and Investment from FINSIA, and is a member of the Australian Institute of Company Directors (AICD).